RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Shanghai Pharmaceuticals Holding Co Stock

Shanghai Pharmaceuticals Holding Co Debt 2025

Shanghai Pharmaceuticals Holding Co Debt

34,371.72 CNY

Ticker

601607.SS

ISIN

CNE000000C82

In 2025, Shanghai Pharmaceuticals Holding Co's total debt was 34,371.72 CNY, a 47.73% change from the 23,267.03 CNY total debt recorded in the previous year.

Shanghai Pharmaceuticals Holding Co Aktienanalyse

What does Shanghai Pharmaceuticals Holding Co do?

Shanghai Pharmaceuticals Holding Co Ltd is a multinational corporation in the pharmaceutical industry based in Shanghai, China. The company was founded in 1994 and has been listed on the Shanghai Stock Exchange since 2007. It has become one of China's largest and most respected pharmaceutical companies over the years. The company's business model is based on the production and distribution of pharmaceutical products, particularly generics and patented medicines. The company produces and markets a wide range of drugs for the treatment of various diseases such as cancer, diabetes, and heart diseases. In addition, the company has achieved a strong position in the research and development of new drugs and has an extensive infrastructure for the production of drugs and biotechnology products. The company consists of various divisions, including the Shanghai Pharma Group, Shanghai Pharmaceuticals (USA) Inc., Shanghai Pharma Healthcare Co. Ltd., and Shanghai Pharma Biotech Co. Ltd. These companies cover a wide range of activities, including research and development, production and distribution, as well as marketing and customer service. The Shanghai Pharma Group includes various business areas such as chemicals and materials, biotechnology, distribution and retail, as well as medical devices and services. Shanghai Pharmaceuticals (USA) Inc. offers high-quality generics, while Shanghai Pharma Healthcare Co. Ltd. focuses on the online sale of medicines. Shanghai Pharma Biotech Co. Ltd. is involved in the development and marketing of biopharmaceuticals. The products offered by Shanghai Pharmaceuticals Holding Co Ltd. include a variety of drugs, dietary supplements, traditional Chinese medicines, and cosmetic products. The company has also specialized in the production of vaccines and the manufacture of active ingredients for export. In recent years, the company has made several significant acquisitions to expand its presence and influence in the global market. In 2015, it acquired Israel-based Alvogen Group, which specializes in the development and marketing of generics and biosimilar medicines. In 2016, Shanghai Pharma acquired a majority stake in China Medical System Holdings, a leading provider of innovative drugs and diagnostic products in China. Furthermore, the company has also invested in research and development to strengthen its position in the global competition. With its modern research and development facilities and strategic partnerships at home and abroad, the company aims to develop innovative drugs in vital therapeutic categories currently needed by patients. Overall, Shanghai Pharmaceuticals Holding Co Ltd offers a wide range of pharmaceutical products and services to meet the requirements and needs of patients and customers worldwide. With a focus on research and development, as well as through strategic acquisitions and partnerships, the company has strengthened its presence in the global pharmaceutical industry and positioned itself as one of the world's largest and most influential companies in this sector. Shanghai Pharmaceuticals Holding Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Shanghai Pharmaceuticals Holding Co's Debt Structure

Shanghai Pharmaceuticals Holding Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Shanghai Pharmaceuticals Holding Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Shanghai Pharmaceuticals Holding Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Shanghai Pharmaceuticals Holding Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Shanghai Pharmaceuticals Holding Co stock

What is the debt of Shanghai Pharmaceuticals Holding Co this year?

Shanghai Pharmaceuticals Holding Co has a debt level of 34,371.72 CNY this year.

What was the debt of Shanghai Pharmaceuticals Holding Co compared to the previous year?

The debt of Shanghai Pharmaceuticals Holding Co has increased by 47.73% compared to the previous year increased.

What are the consequences of high debt for investors in Shanghai Pharmaceuticals Holding Co?

High debt can pose a risk for investors of Shanghai Pharmaceuticals Holding Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Shanghai Pharmaceuticals Holding Co?

Low debt means that Shanghai Pharmaceuticals Holding Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Shanghai Pharmaceuticals Holding Co affect the company?

An increase in debt of Shanghai Pharmaceuticals Holding Co can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Shanghai Pharmaceuticals Holding Co affect the company?

A reduction in debt of Shanghai Pharmaceuticals Holding Co can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Shanghai Pharmaceuticals Holding Co?

Some factors that can influence the debt of Shanghai Pharmaceuticals Holding Co include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Shanghai Pharmaceuticals Holding Co so important for investors?

The debts of Shanghai Pharmaceuticals Holding Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Shanghai Pharmaceuticals Holding Co take to change the debt?

To change the debt, Shanghai Pharmaceuticals Holding Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Shanghai Pharmaceuticals Holding Co pay?

Over the past 12 months, Shanghai Pharmaceuticals Holding Co paid a dividend of 0.61 CNY . This corresponds to a dividend yield of about 3.03 %. For the coming 12 months, Shanghai Pharmaceuticals Holding Co is expected to pay a dividend of 0.65 CNY.

What is the dividend yield of Shanghai Pharmaceuticals Holding Co?

The current dividend yield of Shanghai Pharmaceuticals Holding Co is 3.03 %.

When does Shanghai Pharmaceuticals Holding Co pay dividends?

Shanghai Pharmaceuticals Holding Co pays a quarterly dividend. This is distributed in the months of August, August, August, October.

How secure is the dividend of Shanghai Pharmaceuticals Holding Co?

Shanghai Pharmaceuticals Holding Co paid dividends every year for the past 0 years.

What is the dividend of Shanghai Pharmaceuticals Holding Co?

For the upcoming 12 months, dividends amounting to 0.65 CNY are expected. This corresponds to a dividend yield of 3.21 %.

In which sector is Shanghai Pharmaceuticals Holding Co located?

Shanghai Pharmaceuticals Holding Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shanghai Pharmaceuticals Holding Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shanghai Pharmaceuticals Holding Co from 9/24/2024 amounting to 0.08 CNY, you needed to have the stock in your portfolio before the ex-date on 9/24/2024.

When did Shanghai Pharmaceuticals Holding Co pay the last dividend?

The last dividend was paid out on 9/24/2024.

What was the dividend of Shanghai Pharmaceuticals Holding Co in the year 2024?

In the year 2024, Shanghai Pharmaceuticals Holding Co distributed 0.61 CNY as dividends.

In which currency does Shanghai Pharmaceuticals Holding Co pay out the dividend?

The dividends of Shanghai Pharmaceuticals Holding Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Shanghai Pharmaceuticals Holding Co

Our stock analysis for Shanghai Pharmaceuticals Holding Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shanghai Pharmaceuticals Holding Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.